Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan/Amlodipine FDC vs Amlodipine Monotherapy in Hypertension
NCT00558428Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2007
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of telmisartan in essential hypertension, sponsored by Boehringer Ingelheim. Started Oct 2007; status: completed.
02
Drugs
telmisartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00558428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00558428.